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1011-105 How Does Myocardial Inducible Nitric Oxide Synthase 
Gene Expression Relate to Heart Failure Severity and to 
Subsequent Left Ventricular Reverse Remodeling in 
Patients With Chronic Heart Failure?
W. H. Wilson Tang, Fernando Lopez, Y. Gail Yee, Anne Mullin, Ying Zhang, Michael B. 
Fowler, Stanford University, Stanford, CA
Background: Previous work has shown that patients with advanced HF have higher lev-
els of mNOS2 gene expression compared to normal controls. We examined mNOS2
expression in patients with varying degrees of HF severity and examined the relationship
between mNOS2 expression and subsequent reverse remodeling.
Methods: We performed endomyocardial biopsies on 45 ambulatory patients with
chronic HF (NYHA II-III, LV ejection fraction (LVEF) <45%). To quantify the severity of HF,
plasma NT-proBNP (Roche) was measured during the procedure. Intensity of mNOS2
gene expression was determined using quantitative TaqMan RT-PCR (in ng/mg tissue).
Reverse remodeling was estimated by change in LVEF, determined by serial echo >6
months apart.
Results: Myocardial NOS2 expression correlated inversely with plasma NT-proBNP lev-
els (r= –0.40, p=0.02, see Figure), but not with baseline LVEF (r=0.09, p=0.56). Further-
more, mNOS2 expression correlated directly with improvement in LVEF (r=0.50, p=0.03)
in the subset of patients with echo follow-up (n=19).
Conclusions: Low levels of mNOS2 expression are associated with more advanced HF
and decreased likelihood of subsequent LV reverse remodeling in patients with chronic
HF. These observations do not support the hypothesis that increased mNOS2 expression
impairs LV function and leads to the progression of HF. Rather, increased mNOS2
expression identifies a subset of patients with advanced HF who still have the potential
for subsequent reverse remodeling.
1011-106 One-Minute Heart Rate Recovery After Cycloergometer-
Exercise Test as a Predictor of Mortality in a Cohort of 
1,420 Real-Life Exercise Test Candidates: Substantial 
Differences With the Treadmill Derived Parameter
Nicola Gaibazzi, Nicola Petrucci, Vigilio Ziacchi, Ospedale Civile, Desenzano del Garda-
BS, Italy
Background: Previous studies have shown a strong reverse association between one-
minute heart rate recovery(1min-HRR) after exercising on a treadmill and all-cause mor-
tality.We sought to determine whether the results could be replicated in a large popula-
tion of "real world" exercise-ECG candidates, using a standard bicycle exercise test.
Methods and Results: 1,420 consecutive patients underwent ECG exercise-test using
our standard cycloergometer protocol between 1991 and 1997. We tested 3 pre-speci-
fied cutpoint-values of 1min-HRR, derived from previous studies using treadmill(Kaplan-
Meier curves for one of these values are reported in Fig.1) to check whether they could
discriminate a higher-risk group for all-cause mortality; furthermore we tested the possi-
ble association between 1min-HRR as a continuous variable and mortality, using logistic
regression. Both statistical methods showed lack of statistically significant association
between 1min-HRR and all-cause mortality.A weak trend towards inverse association,
although not statistically significant, could not be excluded.
Conclusion: We could not validate the clear-cut results from some previous studies per-
formed using treadmill exercise-test.Results of our study only can not exclude a mild
inverse association between 1min-HRR measured after cycloergometer exercise-test
and all-cause mortality.1min-HRR measured after cycloergometer exercise-test should
probably be discarded as a clinically useful prognostic marker.
1011-107 Enhanced Left Ventricular Systolic Function Early in 
Type II Diabetic Mice
Jorge A. Alvarez, Maricela Reyes, Mark E. Steinhelper, Danny Escobedo, Gregory 
Freeman, Marc D. Feldman, University of Texas Health Science Center, San Antonio, TX
Background: Early in type II Diabetes(DM) the heart is exposed to increased levels of
the substrates glucose and free fatty acids. While isolated heart studies have shown
increased relation between left ventricular(LV) function and substrate concentration,
echocardiography of the intact mice model show decrease in LV function. In genetic mod-
els of DM since LV function is load sensitive, the true state of LV function in early DM
remains unknown. Thus, we hypothesize that early in DM there is enhanced LV systolic
function due to increased energy supply.
Methods: Type II Diabetic mice (BKS.Cg-m +/+ Leprdb (db/db, n = 7) and paired non-dia-
betic wildtype (WT, n = 9) were sedated with ip Etomidate and Urethane, intubated, and
subjected to thoracotomy. A miniaturized LV catheter(Millar, TX) and dual frequency con-
ductance system were used. Ascending aortic flow was determined (Transonics, NY) for
calibration. LV pressure-volume relations were defined at rest and transient occlusion of
the aorta. Body and heart weight were recorded.
Results: Despite greater body weight, the db/db mice had the same heart weight and
afterload as the WT. An enhancement of LV contractility is shown in the table for the db/
db mice in 4 of 5 parameters examined.
Discussion: We show for the first time, using load independent technique to study intact
mice, that early in Diabetes LV contraction is enhanced. This suggests that a positive
relation between circulating substrate level and myocardial performance is present in vivo
in this condition.
1011-108 Cardiac Responses to Intracoronary-Delivered Stem 
Cells in Apolipoprotein-Null Mice: Assessment by 
Langendorff Perfusion
Shu Li, Jing Lin, Eric Lenehan, Mitra Rajabi, Rosalinda Madonna, Corina Rosales, 
James T. Willerson, Yong J. Geng, The University of Texas Medical School at Houston, 
Houston, TX, Texas Heart Institute, Houston, TX
Background: Apolipoprotein-E (apoE-/-) mice develop hypercholesterolemia eventually
leading to atherosclerosis and ischemic heart failure. Stem cell therapy has been impli-
cated for treating patients with heart failure. This study aimed at determining the efficacy
of cardiac stem cell therapy in an atherosclerosis-prone animal model.
Methods: The hearts of apoE-/- (n=6) and wild type C57BL/6J (n=12) mice were isolated
and perfused with bisbensimide-labeled embryonic stem cells (ESCs) via a Langendorff
device. The hemodaynamic parameters, e.g. coronary flow (CF), heart rate (HR), left
ventricular peak pressure (LVP), +dp/dtmax, and -dp/dtmax, were recorded at different
time points before, during and after ESCs perfusion.
Results: Both apoE-/- and wild type mouse hearts underwent similar cardiac functional
Control Diabetic P value
BW (g) 23 ± 1 48 ± 1 0.00001
HW (mg) 114 ± 3 110 ± 5 0.54
HR (bpm) 471 ± 16 495 ± 13 0.30
Pmax (mmHg) 82 ± 4 121 ± 5 0.00001
EF (%) 53 ± 5 64 ± 5 0.20
Ea (mmHg/µl) 10 ±  3 15 ±  4 0.30
Power/EDV(mWatts/µl2) 91 ± 24 189 ± 32 0.03
dp/dtmax(mmHg/sec) 6,531 ± 1126 11,669 ± 902 0.003
PRSW (mmHg) 69 ± 11 107 ± 9 0.02
E'max(mmHg/µl) 20 ±  6 137 ±  43 0.03
dp/dt-EDV (mmHg x µl/sec) 457 ± 132 1,020 ± 251 0.07
